- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05104411
Rehabilitation in Severely Ill Inpatients With COVID-19
July 15, 2022 updated by: Jaewon Beom, Seoul National University Bundang Hospital
Comprehensive Rehabilitation in Severely Ill Inpatients With COVID-19: A Cohort Study in a Tertiary Hospital
Inpatient rehabilitation of severe-to-critical COVID-19 patients(A longitudinal, single-center retrospective cohort)
Study Overview
Detailed Description
Patients who underwent intensive care at least two days and classified as severe-to-critical COVID-19 (WHO ordinal scale 5-7) were enrolled.
Patients received comprehensive rehabilitation including active exercise program, nutritional support, and psychological support.
Study Type
Observational
Enrollment (Actual)
37
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seongnam-si, Korea, Republic of
- Seoul National University Bundang Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Severe COVID-19 (WHO ordinal scale 5-7) who participated in the inpatient rehabilitation program
Description
Inclusion Criteria:
COVID-19 patients who
- underwent intensive care at least two days,
- eventually got negative conversion with two consecutive tests,
- were classified as severe COVID-19 (WHO ordinal scale 5-7) and
- participated in the inpatient rehabilitation program were included.
Exclusion Criteria:
COVID-19 patients who died (WHO ordinal scale 8) before discharge were excluded
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of Functional Ambulation Classification
Time Frame: at baseline, immediately after rehabilitation completion, and 1-month after rehabilitation completion
|
0~5 score.
FAC 0(Nonfunctional ambulator), FAC1(Ambulator, dependent on physical assistance - Indicates a patient who requires continuous manual contact to support body weight as well as to maintain balance or to assist coordination), FAC 2(Ambulator, dependent on physical assistance - Indicates a patient who requires intermittent or continuous light touch to assist balance or coordination), FAC3(Ambulator, dependent on supervision), FAC4(Ambulator, independent level surface only), FAC5(Ambulator, independent).
Higher score means better outcome.
|
at baseline, immediately after rehabilitation completion, and 1-month after rehabilitation completion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of Appendicular skeletal muscle mass index (ASMI)
Time Frame: at baseline, immediately after rehabilitation completion, and 1-month after rehabilitation completion
|
[Kilogram Per Square Meter]
|
at baseline, immediately after rehabilitation completion, and 1-month after rehabilitation completion
|
|
Change of Medical Research Council (MRC) sum score
Time Frame: at baseline, immediately after rehabilitation completion, and 1-month after rehabilitation completion
|
0~60 score.
|
at baseline, immediately after rehabilitation completion, and 1-month after rehabilitation completion
|
|
Change of handgrip strength
Time Frame: at baseline, immediately after rehabilitation completion, and 1-month after rehabilitation completion
|
[Lb].
|
at baseline, immediately after rehabilitation completion, and 1-month after rehabilitation completion
|
|
Change of number of 1-min sit-to-stand
Time Frame: at baseline, immediately after rehabilitation completion, and 1-month after rehabilitation completion
|
Number of repetitions of sit-to-stand within one minute.
Higher score means better outcome.
|
at baseline, immediately after rehabilitation completion, and 1-month after rehabilitation completion
|
|
Change of walking speed
Time Frame: at baseline, immediately after rehabilitation completion, and 1-month after rehabilitation completion
|
[meter per second].
Walking speed is measured by 10-meter walking test.
If a patient cannot accomplish 10-meter walking test, 4-meter walking test is used instead.
Higher score means better outcome.
|
at baseline, immediately after rehabilitation completion, and 1-month after rehabilitation completion
|
|
Change of Berg balance scale
Time Frame: at baseline, immediately after rehabilitation completion, and 1-month after rehabilitation completion
|
0~56 score.
Berg balance scale is 14-item objective measure that assesses static balance and fall risk in adults.
Each item consists of a five-point ordinal scale(0 to 4), with 0 indicating the lowest level of function and 4 the highest level of function.
Higher score means better outcome.
|
at baseline, immediately after rehabilitation completion, and 1-month after rehabilitation completion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jaewon Beom, MD, PhD, Department of Rehabilitation Medicine, Seoul National University Bundang Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 14, 2021
Primary Completion (Actual)
September 8, 2021
Study Completion (Actual)
July 15, 2022
Study Registration Dates
First Submitted
October 22, 2021
First Submitted That Met QC Criteria
October 30, 2021
First Posted (Actual)
November 3, 2021
Study Record Updates
Last Update Posted (Actual)
July 19, 2022
Last Update Submitted That Met QC Criteria
July 15, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- B-2108-705-112
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19
-
PfizerActive, not recruitingCOVID-19 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | COVID-19 Vaccines | SARS-CoV-2 Infection, COVID19 | COVID-19 Vaccination | SARS-CoV-2 Infection, COVID-19 | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionUnited States
-
Shanghai Public Health Clinical CenterNot yet recruiting
-
Duke UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RecruitingPost COVID-19 Condition | Post COVID-19 | Post COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID-19 Condition (PCC)Germany
-
PfizerRecruitingRespiratory Tract Diseases | COVID-19 | Pneumonia | Lung Diseases | Coronavirus Disease 2019 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | Upper Respiratory Tract Infections | Respiratory Tract Infection | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionBelgium
-
ModeX Therapeutics, An OPKO Health CompanyRecruitingCOVID -19 | COVID-19 (Prevention)United States
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRecruitingFatigue | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19 | Long-COVID | Post-COVID ConditionCanada
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
RSUP PersahabatanCompletedPost COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID Syndrome Long CovidIndonesia
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
Clinical Trials on Rehabilitative intervention
-
Ariel UniversityASST Santi Paolo e CarloCompleted
-
Fondazione Don Carlo Gnocchi OnlusCompletedStroke | RehabilitationItaly
-
Azienda USL Reggio Emilia - IRCCSCompletedCancer CachexiaItaly
-
Johns Hopkins UniversityNational Institute on Aging (NIA)Completed
-
Cleveland Chiropractic CollegeDurban University of TechnologyUnknownChronic Ankle InstabilitySouth Africa
-
University of Roma La SapienzaCompletedPain | Pain, Postoperative | Breast Surgery | Breast Cancer | Pain, Chronic | Breast Cancer Lymphedema | Mastectomy; LymphedemaItaly
-
Istituti Clinici Scientifici Maugeri SpARecruitingDiabetes Mellitus | NeuropathyItaly
-
Rush University Medical CenterRecruitingLabral Tear, Glenoid | Femoral Acetabular ImpingementUnited States
-
Dr. Sandra FucileCompletedInfant Development | Infant, Very Low Birth Weight | Infant,PrematureCanada
-
University of HoustonThe University of Texas Health Science Center, Houston; TIRR Memorial HermannRecruitingStroke | Chronic Stroke | Hemiparetic StrokeUnited States